1 May 2022 false No description of principal activity Taxfiler 2023.15 11961976business:PrivateLimitedCompanyLtd2022-05-012023-04-30 119619762022-04-30 119619762022-05-012023-04-30 11961976business:AuditExemptWithAccountantsReport2022-05-012023-04-30 11961976business:FilletedAccounts2022-05-012023-04-30 119619762023-04-30 11961976business:Director12022-05-012023-04-30 11961976business:RegisteredOffice2022-05-012023-04-30 119619762022-04-30 11961976core:AfterOneYear2023-04-30 11961976core:AfterOneYear2022-04-30 11961976core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 11961976core:ShareCapitalcore:PreviouslyStatedAmount2022-04-30 11961976core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 11961976core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-04-30 11961976core:PreviouslyStatedAmount2023-04-30 11961976core:PreviouslyStatedAmount2022-04-30 11961976business:SmallEntities2022-05-012023-04-30 11961976countries:EnglandWales2022-05-012023-04-30 11961976core:WithinOneYear2023-04-30 11961976core:WithinOneYear2022-04-30 119619762021-05-012022-04-30 iso4217:GBP xbrli:pure
Company Registration No. 11961976 (England and Wales)
Gmed Chempharm Co., Limited Unaudited accounts for the year ended 30 April 2023
Gmed Chempharm Co., Limited Unaudited accounts Contents
Page
- 2 -
Gmed Chempharm Co., Limited Company Information for the year ended 30 April 2023
Director
An Lai Zhang
Company Number
11961976 (England and Wales)
Registered Office
Unit 39a St Olavs Court City Business Centre Lower Road London SE16 2XB
Accountants
LJW Accountants Limited 27 Hardy Avenue Dartford Kent DA1 2FE
- 3 -
Gmed Chempharm Co., Limited Statement of financial position as at 30 April 2023
2023 
2022 
Notes
£ 
£ 
Current assets
Debtors
438,821 
439,030 
Cash at bank and in hand
50,612 
5,520 
489,433 
444,550 
Net current assets
489,433 
444,550 
Total assets less current liabilities
489,433 
444,550 
Creditors: amounts falling due after more than one year
(478,774)
(434,831)
Net assets
10,659 
9,719 
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
9,659 
8,719 
Shareholders' funds
10,659 
9,719 
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 9 March 2024 and were signed on its behalf by
An Lai Zhang Director Company Registration No. 11961976
- 4 -
Gmed Chempharm Co., Limited Notes to the Accounts for the year ended 30 April 2023
1
Statutory information
Gmed Chempharm Co., Limited is a private company, limited by shares, registered in England and Wales, registration number 11961976. The registered office is Unit 39a St Olavs Court, City Business Centre, Lower Road, London, SE16 2XB.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
4
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Other debtors
1,000 
1,000 
Amounts falling due after more than one year
Trade debtors
437,821 
438,030 
5
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Trade creditors
391,628 
362,549 
Other creditors
673 
2,239 
Taxes and social security
221 
1,267 
Loans from directors
86,252 
68,776 
478,774 
434,831 
- 5 -
Gmed Chempharm Co., Limited Notes to the Accounts for the year ended 30 April 2023
6
Average number of employees
During the year the average number of employees was 0 (2022: 1).
- 6 -